Trial Radar AI

Let's discuss and explore clinical trials with Bristol-Myers Squibb as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.
37 Clinical Trials
 
Study Type
Interventional
×
 
Study Title
Status
Deucravacitinib in the Treatment of Cicatricial Alopecias NCT07508488
Not yet recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680
Not yet recruiting
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India NCT07459543
Not yet recruiting
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis NCT07441408
Not yet recruiting
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively NCT07424404
Recruiting
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia NCT07423546
Not yet recruiting
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants NCT07422298
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis NCT07412704
Not yet recruiting
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis NCT07388277
Not yet recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) NCT07361510
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) NCT07361497
Recruiting
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML NCT07355335
Not yet recruiting
A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (Mezi-KD) NCT07348393
Not yet recruiting
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (Breakfree-SSc) NCT07335562
Not yet recruiting
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma NCT07333261
Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer NCT07325136
Recruiting
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma NCT07297212
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) NCT07293351
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) NCT07291076
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) NCT07288567
Recruiting
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder NCT07285798
Not yet recruiting
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism NCT07284745
Not yet recruiting
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer NCT07283705
Suspended
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants. NCT07283263
Recruiting
KarXT Concentrations in the Breast Milk and Plasma of Lactating Females NCT07257120
Recruiting
A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer NCT07255404
Recruiting
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment NCT07248839
Not yet recruiting
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants NCT07226817
Recruiting
A Study to Assess the Effect of Food on the Drug Levels of Admilparant NCT07225647
Completed
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants NCT07223671
Completed
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies NCT07223047
Recruiting
Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being NCT07222696
Recruiting
A Study to Evaluate the Effect of KarXT on Urological Safety NCT07221877
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer NCT07221357
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) NCT07221149
Recruiting
The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab. NCT07212062
Not yet recruiting
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants NCT07204418
Recruiting